Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Comment by Benedictuson May 12, 2020 12:39am
165 Views
Post# 31015224

RE:RE:Lickmorris and Benedicktus

RE:RE:Lickmorris and Benedicktus

Nice post liscomorris. I'd put Kyle, the khiron board "village idiot", on ignore, so I've missed whatever disparaging and misinformed remarks he's made about me.

IMO the board would be a far more useful forum if everyone put Kyle on ignore and allowed him to just post into his own sad little echo chamber. He has proven time and again to lack all credibility and resort solely to his copy of the basher 101 handbook. 

This is not to say I do not welcome an all angles view of the company from investors and potential investors here.  It's just that Kyle is incapable of such analysis. 

The latest presentation by Chris and Alvarro archived on the khiron site left me feeling very confident in their strategy and execution. They've navigated the marijuana sector bubble popping and this covid 19 better than the majority of their peers. Their knowledge of the capital markets wrt timing of capital raises and share repurchases shows a keen understanding lost on the likes of the kyles of the world. The medical model and strategy they are pursuing should begin really bearing fruit by late this year. A raise may be needed in Q1 2021 but I'd imagine by then the market will have begun to revalue these guys as serious players with incredible first mover advantage in Lat Am. All imo

<< Previous
Bullboard Posts
Next >>